🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
2.900
-0.070 (-2.36%)
Nov 20, 2026, 3:04 PM CST

SHE:300026 Revenue

Tianjin Chase Sun Pharmaceutical Co.,Ltd had revenue of 918.33M CNY in the quarter ending September 30, 2026, a decrease of -32.16%. This brings the company's total for the last twelve months to 3.90B, down -28.99% year-over-year. In the year 2025, Tianjin Chase Sun Pharmaceutical Co.,Ltd had annual revenue of 4.94B, down -14.55%. That makes Tianjin Chase Sun Pharmaceutical Co.,Ltd the 10,406th largest company in the world by revenue and 1,695th in China.

Revenue (ttm)
3.90B
Revenue Growth
-28.99%
P/S Ratio
2.23
Revenue / Employee
803.55K
Employees
4,852
Market Cap
8.71B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Chinese Medicine Formula Granules and Decoction Pieces 2.46B 49.8%
  • Finished Medicine 1.38B 27.9%
  • Medical Instruments 587.93M 11.9%
  • Excipients and APIs 428.24M 8.7%
  • Others 87.20M 1.8%

By Geography

Chart
  • North China 1.28B 25.9%
  • Eastern China 1.22B 24.8%
  • Central China 830.77M 16.8%
  • Foreign 392.87M 8.0%
  • South-West China 384.36M 7.8%
  • South China 315.91M 6.4%
  • North-East China 259.54M 5.3%
  • North-West China 252.80M 5.1%
Fiscal year ended Dec 31, 2025 See the full SHE:300026 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.94B-841.64M-14.55%
Dec 31, 20245.78B-326.09M-5.34%
Dec 31, 20236.11B-541.17M-8.14%
Jan 1, 20236.65B-1.02B-13.30%
Dec 31, 20217.67B1.18B18.22%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.